The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results